Literature DB >> 35024952

Intramedullary application of local antibiotic bullets for the treatment of long bone fracture related infection.

Preemal Patel1, Alexis-Dimitris Iliadis2, Alexandros Vris2, Nima Heidari2, Alex Trompeter3.   

Abstract

PURPOSE: The optimal means of local antibiotic delivery for fracture related infection is unknown. Until now, intramedullary application of calcium sulphate based local antibiotics has been challenging. We report on the use of a newly available mode of preparation and delivery: the Stimulan Bullet Mat and Introducer (Biocomposites Ltd, Staffordshire, England).
METHODS: A retrospective analysis of prospectively collected data for infection cases at two separate tertiary referral institutions was performed. We included cases of long bone FRI with a retained intramedullary nail, treated with a single stage protocol of metalwork removal, debridement, local antibiotic application using the novel mould and applicator, with additional bony stabilisation and soft tissue reconstruction where required.
RESULTS: All 13 patients achieved infection remission rate with an average follow-up of 19.7 months (range 12-28). All 6 patients with infection around an unhealed fracture achieved union at an average 8 months (range 4-12) from debridement. No patients developed aseptic wound leak.
CONCLUSIONS: Antibiotic impregnated calcium sulphate can be used safely as part of a single stage treatment protocol for the treatment of long bone fracture related infection following intramedullary nailing. We have demonstrated high rates of infection remission and union, using a newly available intramedullary applicator.
© 2022. The Author(s), under exclusive licence to Springer-Verlag France SAS, part of Springer Nature.

Entities:  

Keywords:  Calcium sulphate; Fracture related infection; Local antibiotics; Long bone fractures

Year:  2022        PMID: 35024952     DOI: 10.1007/s00590-022-03205-2

Source DB:  PubMed          Journal:  Eur J Orthop Surg Traumatol        ISSN: 1633-8065


  8 in total

1.  Treatment of infection following intramedullary nailing of tibial shaft fractures-results of the ORS/ISFR expert group survey.

Authors:  Cyril Mauffrey; David J Hak; Peter Giannoudis; Volker Alt; Christoph Nau; Ingo Marzi; Peter Augat; J K Oh; Johannes Frank; Andreas Mavrogenis; Xavier Flecher; Jean-Noel Argenson; Ashok Gavaskar; David Rojas; Yehia H Bedeir
Journal:  Int Orthop       Date:  2018-05-03       Impact factor: 3.075

2.  Current treatment of infected non-union after intramedullary nailing.

Authors:  A Hamish Simpson; Jerry S T Tsang
Journal:  Injury       Date:  2017-05-09       Impact factor: 2.586

3.  Calcium sulfates: what is the evidence?

Authors:  Murray J S Beuerlein; Michael D McKee
Journal:  J Orthop Trauma       Date:  2010-03       Impact factor: 2.512

4.  Infection after fracture fixation of the tibia: Analysis of healthcare utilization and related costs.

Authors:  Willem-Jan Metsemakers; Bart Smeets; Stefaan Nijs; Harm Hoekstra
Journal:  Injury       Date:  2017-03-22       Impact factor: 2.586

5.  A systematic review of the single-stage treatment of chronic osteomyelitis.

Authors:  Bethan Pincher; Carl Fenton; Rathan Jeyapalan; Gavin Barlow; Hemant K Sharma
Journal:  J Orthop Surg Res       Date:  2019-11-28       Impact factor: 2.359

Review 6.  Review of calcium-sulphate-based ceramics and synthetic bone substitutes used for antibiotic delivery in PJI and osteomyelitis treatment.

Authors:  Razvan Ene; Mihai Nica; Dragos Ene; Adrian Cursaru; Catalin Cirstoiu
Journal:  EFORT Open Rev       Date:  2021-05-04

7.  Management of infection after intramedullary nailing of long bone fractures: treatment protocols and outcomes.

Authors:  Kostas G Makridis; Theodoros Tosounidis; Peter V Giannoudis
Journal:  Open Orthop J       Date:  2013-06-14

8.  Intramedullary reaming and irrigation and antibiotic-loaded calcium sulfate implantation for the treatment of infection after intramedullary nailing: a retrospective study of 19 cases.

Authors:  Hong-An Zhang; Chun-Hao Zhou; Xiang-Qing Meng; Jia Fang; Cheng-He Qin
Journal:  BMC Musculoskelet Disord       Date:  2020-10-28       Impact factor: 2.362

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.